Sobi™ Completes Acquisition of Synagis® US Rights From AstraZeneca and Exercises Authorisation to Issue Shares - BioSpace

Sobi™ Completes Acquisition of Synagis® US Rights From AstraZeneca and Exercises Authorisation to Issue Shares  BioSpace

Published: Jan 24, 2019. STOCKHOLM, Jan. 24, 2018 /PRNewswire/ --Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO: SOBI) announced today that it has ...



Comments

Popular posts from this blog

Глушители. Приборы бесшумной стрельбы